During the past decade, Akron General Medical Center conducted 74 clinical trials. In the 10-year time frame, 74 clinical trials started and 91 clinical trials were completed, i.e. on average, 123% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 45 clinical trials were completed. i.e. 214.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Akron General Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 68 trials, followed by "Radiation Therapy Oncology Group" with 45 trials sponsored, "NRG Oncology" with 15 trials sponsored, "Alliance for Clinical Trials in Oncology" with 14 trials sponsored and "SWOG Cancer Research Network" with 14 trials sponsored. Other sponsors include 77 different institutions and companies that sponsored additional 52 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Akron General Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 115 trials as a collaborator, "NRG Oncology" with 33 trials as a collaborator, "Radiation Therapy Oncology Group" with 11 trials as a collaborator, "Eastern Cooperative Oncology Group" with 7 trials as a collaborator and "North Central Cancer Treatment Group" with 7 trials as a collaborator. Other collaborators include 88 different institutions and companies that were collaborators in the rest 67 trials.

According to Clinical.Site data, the most researched conditions in "Akron General Medical Center" are "Breast Cancer" (15 trials), "Prostate Cancer" (11 trials), "Fallopian Tube Transitional Cell Carcinoma" (9 trials), "Head and Neck Cancer" (9 trials) and "Ovarian Endometrioid Adenocarcinoma" (9 trials). Many other conditions were trialed in "Akron General Medical Center" in a lesser frequency.

Most popular intervention types in "Akron General Medical Center" are "Drug" (176 trials), "Other" (105 trials), "Radiation" (74 trials), "Biological" (61 trials) and "Procedure" (44 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (57 trials), "Quality-of-Life Assessment" (42 trials), "radiation therapy" (32 trials), "Paclitaxel" (29 trials) and "Carboplatin" (23 trials). Other intervention names were less common.

The vast majority of trials in "Akron General Medical Center" are 166 trials for "All" genders, 55 trials for "Female" genders and 16 trials for "Male" genders.

Currently, there are NaN active trials in "Akron General Medical Center". undefined are not yet recruiting, 24 are recruiting, 72 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 114 completed trials in Akron General Medical Center, 3 suspended trials, and 18 terminated clinical trials to date.

Out of the total trials that were conducted in Akron General Medical Center, 14 "Phase 1" clinical trials were conducted, 79 "Phase 2" clinical trials and 130 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 13 trials that are defined as “Not Applicable".